You searched for "veterans"

63 results found

FDA grants Lenire tinnitus treatment device De Novo approval

Neuromod Devices Ltd. is proud to announce that the US Food and Drug Administration (FDA) has granted De Novo approval to Lenire.

How long after head and neck cancer diagnosis do patients need opioids?

With the advances in the management of head and neck cancer (HNC), patients tend to survive longer after their diagnosis. These people face the burden of chronic pain management which is strongly associated with HNC. A HNC team in Portland...

Military otolaryngology and its impact on civilian trauma care

Over the centuries, military conflicts and wars have caused both death and injuries and led to improvements in the care of the combat wounded. Military otolaryngologist-head and neck surgeons have been at the forefront of these developments and advances. War...

Ida Institute Celebrates Lise Lotte Bundesen for 15 Years of Leadership Driving Person-Centered Care

Ida Institute Founder Lise Lotte Bundesen will retire as Managing Director in July, 2022. During Bundesen’s 15-year tenure, the nonprofit institute’s impact and influence has grown exponentially.

What’s new in protecting hearing?

Preventing an avoidable hearing loss before it begins would be the public health dream. In this article Kathleen Campbell takes us through one option that is showing the potential to fulfil that ambition. Kathleen explains the development of a preventative...

Controlled clinical trial results for FDA-approved tinnitus treatment device Lenire published in Nature Communications

Nature Communications has published the peer-reviewed results of Neuromod Devices’ TENT-A3 (Treatment Evaluation of Neuromodulation for Tinnitus – Stage A3) clinical trial for the first and only FDA-approved bimodal tinnitus treatment device, Lenire.

Tinnitus treatment device from concept to commercialisation

Innovation in the field of healthcare is fraught with nearly insurmountable challenges. Bringing a novel product to the market requires a new (patentable) idea that can be reduced to practice, manufactured at scale, and can pass all regulatory barriers. In...

Thoughts on war: von Clausewitz revisited

We few, we happy few, we band of brothers; For he to-day that sheds his blood with me Shall be my brother; be he ne’er so vile, This day shall gentle his condition: And gentlemen in England now a-bed Shall...

68th Annual Convention of the Philippine Society of Otolaryngology - Head and Neck Surgery

The world of otolaryngology head and neck surgery continues to evolve at a rapid pace, and nowhere was this more evident than at the 68th Annual Convention of the Philippine Society of Otolaryngology-Head and Neck Surgery (PSO-HNS), held from December 6 to 8, 2024, at the gleaming halls of EDSA Shangri-La Hotel in Manila, Philippines.

Impact of delaying otologic surgery

In this Belgian study, the authors looked at the impact of delaying otologic surgery by sending an online survey to 44 adult patients diagnosed with benign ear pathology whose surgery was postponed due to the COVID-19 pandemic. The questionnaire was...

FDA Approved Lenire Expands Number of US Clinics

Neuromod Devices, the medical technology company that developed tinnitus treatment device, Lenire, has partnered with an additional 24 new US clinics to address the significant demand for the FDA Approved tinnitus treatment device.

New RSM presidents preview the year ahead

Professor Patrick Axon, President of the UK’s Royal Society of Medicine Otology Section and Michelle Wyatt, incoming President of the section of Laryngology and Rhinology, look forward to the year ahead.